Chronic heart failure, selected risk factors and co-morbidities among adults treated for hypertension in a cardiac referral hospital in Cameroon

European Journal of Heart Failure

Volumn 10, Issue 4, 2008, Pages 367-372

  Dzudie, Anastase ^a,b   Kengne, Andre Pascal ^c   Mbahe, Salomon ^b   Menanga, Alain ^d   Kenfack, Monique ^b   Kingue, Samuel ^b,d  

^a Louis Pradel's Cardiovascular Hospital   (France)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF SYDNEY   (Australia)

^d YAOUNDÉ GENERAL HOSPITAL   (Cameroon)

Author keywords

Africa; Cardiomyopathy; Co morbidities; Heart failure; Hypertension; Risk factors

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CAMEROON; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENERAL HOSPITAL; GOUT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAMEROON; CARDIOLOGY SERVICE, HOSPITAL; CHRONIC DISEASE; COMORBIDITY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HOSPITALS, GENERAL; HUMANS; HYPERTENSION; KIDNEY FAILURE; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 41449098536     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.02.009     Document Type: Article

References (33)

1. Cowie M.R., Mosterd A., Wood D.A., et al. The epidemiology of heart failure. Eur Heart J 18 (1997) 208-225
2. Mendez G.F., and Cowie M.R. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol 80 (2001) 213-219
3. Sliwa K., Damasceno A., and Mayosi B.M. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 112 (2005) 3577-3583
4. Amoah A.G., and Kallen C. Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology 93 (2000) 11-18
5. Kingue S., Dzudie A., Menanga A., Akono M., Ouankou M., and Muna W. Nouveau regard sur l'insuffisance cardiaque chronique de l'adulte en Afrique à l'ère de l'Echocardiographie Doppler: Expérience du service de médecine de l'Hôpital Général de Yaoundé. Ann Cardiol Angeiol (Paris) 54 (2005) 276-283
6. Thiam M. Cardiac insufficiency in the African cardiology milieu. 57. Bull Soc Pathol Exot 96 (2003) 217-218
7. Lawes C.M., Vander Hoorn S., Law M.R., Elliott P., MacMahon S., and Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens 24 (2006) 423-430
8. Lawes C.M., Vander Hoorn S., Law M.R., Elliott P., MacMahon S., and Rodgers A. Blood pressure and the global burden of disease 2000: Part 1:estimates of blood pressure level. J Hum Hypertens 3 (2006) 413-422
9. Opie L.H., and Seedat Y.K. Hypertension in Sub-Saharan African populations. Circulation 112 (2007) 3562-3568
10. Connor M.D., Walker R., Modi G., and Warlow C.P. Burden of stroke in black populations in sub-Saharan Africa. Lancet Neurol 6 (2007) 269-278
11. Kengne A.P., and Anderson C.S. The neglected burden of stroke in Sub-Saharan Africa. Int J Stroke 1 (2006) 180-190
12. Devereux R.B. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
13. Wang T.J., Evans J.C., Benjamin E.J., Levy D., LeRoy E.C., and Vasan R.S. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108 (2003) 977-982
14. Anonymous. The sixth Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure (JNC VI). Arch Int Med 157 (1997) 2413-2446
15. Ayodele O.E., Alebiosu C.O., Salako B.L., Awoden O.G., and Abigun A.D. Target organ damage and associated clinical conditions among Nigerians with treated hypertension. Cardiovasc J South Afr 16 (2005) 89-93
16. Vasan R.S., Larson M.G., and Benjamin E.G. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
17. Oyati I.A., Danbauchi S.S., Alhassan M.A., and Isa M.S. Diastolic dysfunction in persons with hypertensive heart failure. J Natl Med Assoc 96 (2004) 968-973
18. Wachtell K., Smith G., Gerdts E., et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am J Cardiol 85 (2000) 466-472
19. Muntwyler J., Cohen-Solal A., Freemantle N., Eastaugh J., Cleland J.G., and Follath F. Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail 6 (2004) 663-668
20. Granger B.B., Swedberg K., Ekman I., et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366 (2005) 2005-2011
21. Granger C.B., McMurray J.J., Yusuf S., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362 (2003) 772-776
22. McMurray J.J., Ostergren J., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362 (2003) 767-771
23. Bibbins-Domingo K., Lin F., Vittinghoff E., Barrett-Connor E., Grady D., and Shlipak M.G. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 44 (2004) 1593-1600
24. Cohen N., Gorelik O., moznino-Sarafian D., et al. Renal dysfunction in congestive heart failure, pathophysiological and prognostic significance. Clin Nephrol 61 (2004) 177-184
25. Aguilar D., Solomon S.D., Kober L., et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation 110 (2004) 1572-1578
26. Ancion A., Lancellotti P., and Pierard L.A. Congestive heart failure and diabetes mellitus. Rev Med Liege 60 (2005) 536-540
27. Bell D.S. Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 115 (2003) 412
28. Aronow W.S. Treatment of heart failure in older persons. Dilemmas with coexisting conditions: diabetes mellitus, chronic obstructive pulmonary disease, and arthritis. Congest Heart Fail 9 (2003) 142-147
29. Le Jemtel T.H., Padeletti M., and Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 49 (2007) 171-180
30. Ceia F., Fonseca C., Mota T., Morais H., et al. Aetiology, comorbidity and drug therapy of chronic heart failure in the real world: the EPICA substudy. Eur J Heart Fail 6 (2004) 801-806
31. Ali A.S., Fenn N.M., Zarowitz B.J., Niemyski P., Vitarelli A., and Gheorghiade M. Epidemiology of atrial fibrillation in patients hospitalized in a large hospital. Panminerva Med 35 (1993) 209-213
32. Heist E.K., and Ruskin J.N. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis 48 (2006) 256-269
33. Kengne A.P., Awah K.P., Fezeu L., and Mbanya J.C. The burden of high blood pressure and related risk factors in urban sub-Saharan Africa: Evidences from Douala in Cameroon. Afr. Health Sci. 7 (2007) 38-44